ACORN CAPITAL ADVISORS, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0002054410 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 19, 2025

Total Value: $150M (100.0% shares, 0.0% debt)

Holdings (22)

CGON CG ONCOLOGY INC 18.5%

Value $27.72M Shares 1,131,501 Est. Cost $34.21 Unrealized -17.8%

URGN UROGEN PHARMA LTD 11.2%

Value $16.77M Shares 1,516,303 Est. Cost $11.97 Unrealized -11.0%

— Y-MABS THERAPEUTICS INC 9.6%

Value $14.33M Shares 3,235,387 Est. Cost $7.44 Unrealized —

TRVI TREVI THERAPEUTICS INC 9.0%

Value $13.49M Shares 2,144,844 Est. Cost $3.31 Unrealized +44.3%

CADL CANDEL THERAPEUTICS INC 8.1%

Value $12.16M Shares 2,152,252 Est. Cost $6.13 Unrealized +33.3%

PBYI PUMA BIOTECHNOLOGY INC 7.8%

Value $11.66M Shares 3,940,052 Est. Cost $2.91 Unrealized +7.6%

BCAX BICARA THERAPEUTICS 5.6%

Value $8.383M Shares 643,382 Est. Cost $20.81 Unrealized -36.2%

TARA PROTARA THERAPEUTICS INC 3.6%

Value $5.452M Shares 1,279,800 Est. Cost $3.23 Unrealized +38.3%

TERN TERNS PHARMACEUTICALS INC 3.6%

Value $5.441M Shares 1,971,264 Est. Cost $6.77 Unrealized -39.7%

OKUR ONKURE THERAPEUTICS INC 3.4%

Value $5.124M Shares 1,439,674 Est. Cost $15.14 Unrealized -62.9%

VSTM VERASTEM INC 3.1%

Value $4.7M Shares 779,498 Est. Cost $3.94 Unrealized +55.1%

HELP CYBIN INC 3.1%

Value $4.663M Shares 734,394 Est. Cost $10.16 Unrealized -14.7%

CRDF CARDIF ONCOLOGY INC 3.0%

Value $4.529M Shares 1,442,308 Est. Cost $3.13 Unrealized +26.5%

— OPTINOSE INC 2.6%

Value $3.877M Shares 422,814 Est. Cost $6.68 Unrealized —

WHWK WHITEHAWK THERAPEUTICS INC 1.4%

Value $2.028M Shares 1,139,363 Est. Cost $2.27 Unrealized +15.3%

— X4 PHARMACEUTICALS INC 1.2%

Value $1.755M Shares 7,310,650 Est. Cost $0.73 Unrealized —

— MURAL ONCOLOGY PLC 1.1%

Value $1.6M Shares 1,269,715 Est. Cost $3.22 Unrealized —

AURA AURA BIOSCIENCES INC 1.0%

Value $1.453M Shares 590,508 Est. Cost $7.57 Unrealized 0.0%

BCAB BIOATLA INC 0.9%

Value $1.411M Shares 4,032,046 Est. Cost $1.68 Unrealized -74.5%

QTTB Q32 BIO INC. 0.9%

Value $1.326M Shares 803,425 Est. Cost $31.58 Unrealized -91.5%

VYNE VYNE THERAPEUTICS INC 0.8%

Value $1.242M Shares 785,938 Est. Cost $2.55 Unrealized -3.5%

ACRV ACRIVON THERAPEUTICS INC 0.5%

Value $823K Shares 405,237 Est. Cost $7.27 Unrealized -25.9%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG ONCOLOGY INC	1,131,501	$27.72M	18.5%	$34.21	-17.8%	COM	156944100
URGN	UROGEN PHARMA LTD	1,516,303	$16.77M	11.2%	$11.97	-11.0%	COM	M96088105
—	Y-MABS THERAPEUTICS INC	3,235,387	$14.33M	9.6%	$7.44	—	COM	984241109
TRVI	TREVI THERAPEUTICS INC	2,144,844	$13.49M	9.0%	$3.31	+44.3%	COM	89532M101
CADL	CANDEL THERAPEUTICS INC	2,152,252	$12.16M	8.1%	$6.13	+33.3%	COM	137404109
PBYI	PUMA BIOTECHNOLOGY INC	3,940,052	$11.66M	7.8%	$2.91	+7.6%	COM	74587V107
BCAX	BICARA THERAPEUTICS	643,382	$8.383M	5.6%	$20.81	-36.2%	COM	055477103
TARA	PROTARA THERAPEUTICS INC	1,279,800	$5.452M	3.6%	$3.23	+38.3%	COM STK	74365U107
TERN	TERNS PHARMACEUTICALS INC	1,971,264	$5.441M	3.6%	$6.77	-39.7%	COM	880881107
OKUR	ONKURE THERAPEUTICS INC	1,439,674	$5.124M	3.4%	$15.14	-62.9%	CLASS A COM	68277Q105
VSTM	VERASTEM INC	779,498	$4.7M	3.1%	$3.94	+55.1%	COM	92337C203
HELP	CYBIN INC	734,394	$4.663M	3.1%	$10.16	-14.7%	COM NEW	23256X407
CRDF	CARDIF ONCOLOGY INC	1,442,308	$4.529M	3.0%	$3.13	+26.5%	COM	14147L108
—	OPTINOSE INC	422,814	$3.877M	2.6%	$6.68	—	COM NEW	68404V209
WHWK	WHITEHAWK THERAPEUTICS INC	1,139,363	$2.028M	1.4%	$2.27	+15.3%	COM	00032Q104
—	X4 PHARMACEUTICALS INC	7,310,650	$1.755M	1.2%	$0.73	—	COM	98420X103
—	MURAL ONCOLOGY PLC	1,269,715	$1.6M	1.1%	$3.22	—	COM	G63365103
AURA	AURA BIOSCIENCES INC	590,508	$1.453M	1.0%	$7.57	0.0%	COM	05153U107
BCAB	BIOATLA INC	4,032,046	$1.411M	0.9%	$1.68	-74.5%	COM	09077B104
QTTB	Q32 BIO INC.	803,425	$1.326M	0.9%	$31.58	-91.5%	COM	746964105
VYNE	VYNE THERAPEUTICS INC	785,938	$1.242M	0.8%	$2.55	-3.5%	COM	92941V308
ACRV	ACRIVON THERAPEUTICS INC	405,237	$823K	0.5%	$7.27	-25.9%	COMMON STOCK	004890109